Pierre-Antoine Bonnet

6PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunologyCheminformatics and quantitative structure-activity relationshipsNanoelectronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2025
The Novel Imiqualine EAPB02303 Is a Potent Drug for Treating Acute Myeloid Leukemia.

Perla Makhoul, Rita Hleihel, Shaymaa Itani

|May 07, 2025
Research Progress on the Structure-activity Relationship and Mechanism of Flavonoid Derivatives in the Treatment of Lung Cancer.

Jiacheng Yao, Feng Zhu, Yikun Feng

|Jun 27, 2024
Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model.

Shaymaa Itani, Maguy Hamie, Reem El Jammal

|Jul 29, 2023
[1,2,4]triazolo[4,3-a]quinoxaline as Novel Scaffold in the Imiqualines Family: Candidates with Cytotoxic Activities on Melanoma Cell Lines.

Cindy Patinote, Sandy Raevens, Amélie Baumann

|Apr 12, 2022
EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.

Hala Skayneh, Batoul Jishi, Rita Hleihel

|Jul 09, 2019
Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series.

Nour Bou Karroum, Georges Moarbess, Jean-François Guichou

Pageof 1

Frequent Collaborators

3 joint publications

Hiba El Hajj

2 joint publications

Cindy Patinote

2 joint publications

Carine Deleuze-Masquéfa

1 joint publications

Mark Doumit